Evidence map›Paper›PMID 27965662›Full record

ArticleFrontiers in immunology2016

Visceral Leishmaniasis Patients Display Altered Composition and Maturity of Neutrophils as well as Impaired Neutrophil Effector Functions.

Endalew Yizengaw, Mulusew Getahun, Fitsumbrhan Tajebe, Edward Cruz Cervera, Emebet Adem, Getnet Mesfin, Asrat Hailu, Gert Van der Auwera, Vanessa Yardley, Mulualem Lemma and 10 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 45 citations in OpenAlex.

  1. Neutrophil-ACS infectious diseases · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Elucidating the role played by bone marrow in visceral leishmaniasis.Frontiers in cellular and infection microbiology · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Infection of Human Neutrophils WithFrontiers in cellular and infection microbiology · 2019
    Article
  15. Article
  16. RIPK1-RIPK3-MLKL-Associated Necroptosis DrivesFrontiers in immunology · 2018
    Article
  17. Frontiers in microbiology · 2018
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 4 countries.

Endalew YizengawDepartment of Immunology, University of Gondar , Gondar , Ethiopia.
Mulusew GetahunDepartment of Immunology, University of Gondar , Gondar , Ethiopia.
Fitsumbrhan TajebeDepartment of Immunology, University of Gondar , Gondar , Ethiopia.
Edward Cruz CerveraDepartment of Medicine, Imperial College London , London , UK.
Emebet AdemLeishmaniasis Research and Treatment Centre, Gondar University , Gondar , Ethiopia.
Getnet MesfinDepartment of Immunology, University of Gondar , Gondar , Ethiopia.
Asrat HailuDepartment of Microbiology, Immunology and Parasitology, Addis Ababa University , Addis Ababa , Ethiopia.
Gert Van der AuweraDepartment of Biomedical Sciences, Institute of Tropical Medicine , Antwerp , Belgium.
Vanessa YardleyDepartment of Immunology and Infection, London School of Hygiene and Tropical Medicine , London , UK.
Mulualem LemmaDepartment of Internal Medicine, University of Gondar , Gondar , Ethiopia.
Ziv SkhedyDepartment of Mathematics and Statistics, University of Hasselt , Hasselt , Belgium.
Ermias DiroLeishmaniasis Research and Treatment Centre, Gondar University , Gondar , Ethiopia.
Arega YeshanewLeishmaniasis Research and Treatment Centre, Gondar University , Gondar , Ethiopia.
Roma MelkamuLeishmaniasis Research and Treatment Centre, Gondar University , Gondar , Ethiopia.
Bewketu MengeshaLeishmaniasis Research and Treatment Centre, Gondar University , Gondar , Ethiopia.
Manuel ModolellDepartment of Cellular Immunology, Max-Planck-Institute for Immunobiology and Epigenetics , Freiburg , Germany.
Markus MunderThird Department of Medicine (Hematology, Oncology, and Pneumology), University Medical Center Mainz , Mainz , Germany.
Ingrid MüllerDepartment of Medicine, Imperial College London , London , UK.
Yegnasew TakeleDepartment of Medicine, Imperial College London, London, UK; Leishmaniasis Research and Treatment Centre, Gondar University, Gondar, Ethiopia.
Pascale KropfDepartment of Medicine, Imperial College London , London , UK.
University of Gondar · ETImperial College London · GBAddis Ababa University · ETHasselt University · BEInstituut voor Tropische Geneeskunde · BELondon School of Hygiene & Tropical Medicine · GBMax Planck Institute of Immunobiology and Epigenetics · DEUniversity Medical Center of the Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunologically, active visceral leishmaniasis (VL) is characterized by profound immunosuppression, severe systemic inflammatory responses, and an impaired capacity to control parasite replication. Neutrophils are highly versatile cells, which play a crucial role in the induction as well as the resolution of inflammation, the control of pathogen replication, and the regulation of immune responses. Neutrophil functions have been investigated in human cutaneous leishmaniasis; however, their role in human VL is poorly understood. In the present study we evaluated the activation status and effector functions of neutrophils in patients with active VL and after successful anti-leishmanial treatment. Our results show that neutrophils are highly activated and have degranulated; high levels of arginase, myeloperoxidase, and elastase, all contained in neutrophils' granules, were found in the plasma of VL patients. In addition, we show that a large proportion of these cells are immature. We also analyzed effector functions of neutrophils that are essential for pathogen clearance and show that neutrophils have an impaired capacity to release neutrophil extracellular traps, produce reactive oxygen species, and phagocytose bacterial particles, but not

Indexed as

neutrophil extracellular trapsneutrophilsphagocytosisreactive oxygen speciesvisceral leishmaniasis

Identifiers

PMID27965662
PMCPMC5126105
OpenAlexW2557912648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.